CEDAZURIDINE AND DECITABINE

979 reported adverse events

Drug classes: Nucleoside Metabolic Inhibitor [EPC]

These side effects are most commonly reported by patients taking CEDAZURIDINE AND DECITABINE:

# Side effect Count
0 FATIGUE 144
1 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 142
2 CYTOPENIA 129
3 PRODUCT USE IN UNAPPROVED INDICATION 120
4 PLATELET COUNT DECREASED 115
5 DEATH 114
6 WHITE BLOOD CELL COUNT DECREASED 92
7 OFF LABEL USE 78
8 NAUSEA 73
9 TRANSFUSION 71
See all common reactions for CEDAZURIDINE AND DECITABINE

CEDAZURIDINE AND DECITABINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BIOPSY SITE COMPLICATION 1 0.1000
1 ISOCITRATE DEHYDROGENASE GENE MUTATION 1 0.0588
2 SOFT TISSUE FOREIGN BODY 1 0.0435
3 BILE DUCT STENT REMOVAL 1 0.0370
4 HYPERPLASTIC CHOLECYSTOPATHY 4 0.0296
5 CATHETER SITE HYPERSENSITIVITY 1 0.0250
6 SUBCAPSULAR SPLENIC HAEMATOMA 1 0.0222
7 PLASMA CELLS DECREASED 1 0.0200
8 RED BLOOD CELL TRANSFUSION 8 0.0195
9 PRODUCT REGIMEN CONFUSION 1 0.0192
See all enriched reactions for CEDAZURIDINE AND DECITABINE